Genetics implicate common mechanisms in autism and schizophrenia: synaptic activity and immunity

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Autism spectrum disorder (ASD) and schizophrenia (SCHZ) diagnoses are increasing, necessitating better understanding of their underlying mechanisms.
• Despite strong genetic components, the specific genetic variants and cellular pathologies for ASD and SCHZ remain largely unknown.
• Current treatments focus on symptom management, highlighting the need for disease-modifying therapies.

Purpose of the Study:

• To explore the shared genetic and cellular mechanisms contributing to ASD and SCHZ.
• To identify potential therapeutic targets by elucidating the molecular underpinnings of these psychiatric disorders.

Main Methods:

• Leveraging next-generation sequencing technologies.
• Analyzing data from large genetic consortia.
• Investigating gene expression, synaptic function, and immune system involvement.

Main Results:

• Identified overlapping cellular mechanisms in ASD and SCHZ, including alterations in gene expression regulation, synaptic architecture and activity, and immunity.
• Observed convergence of these pathways in aberrant synaptic plasticity and altered brain connectivity.
• Highlighted the complex genetic architecture with numerous low-risk variants contributing to disease susceptibility.

Conclusions:

• ASD and SCHZ, despite distinct phenotypes, share common molecular pathways.
• Aberrant synaptic plasticity is a potential converging mechanism.
• Further genetic research is crucial for developing effective, disease-modifying treatments for ASD and SCHZ.